Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective

Erik V Soloff; Carolyn L Wang

doi:10.34067/KID.0000502019

Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective

Kidney360. 2020 Jan 9;1(2):123-126. doi: 10.34067/KID.0000502019. eCollection 2020 Feb 27.

Authors

Erik V Soloff¹, Carolyn L Wang¹

Affiliation

¹ Radiology Department, University of Washington, Seattle, Washington.

No abstract available

Keywords: Chronic Kidney Disease; Gadolinium; chronic kidney disease; gadolinium deposition; gadolinium-based contrast agent; nephrogenic systemic fibrosis; radiology.

MeSH terms

Contrast Media / adverse effects
Gadolinium / adverse effects
Humans
Nephrogenic Fibrosing Dermopathy*
Radiologists
Renal Insufficiency, Chronic* / diagnosis

Substances

Contrast Media
Gadolinium